A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the International Classification of Diseases Tenth Revision diagnosis code (U09.9): a population-based cohort study.

"Declaration of competing interest MB has funding by research grants from Svenska sällskapet för Medicinsk Forskning (SSMF), Swedish Research Council for Health, Working Life, and Welfare (FORTE), and Mary von Sydow's foundation; SL has funding by a Swedish government research grant through the ALF-agreement; MG has funding by a Swedish government research grant through the ALF-agreement and from Formas, Swedish Research Council for Sustainable Development; MG has received personal honoraria from Amgen, Biogen, BMS, Gilead, GSK/ViiV, Janssen-Cilag, MSD, Novocure, and Novo Nordic and participated on a scientific advisory board for Astra Zeneca (DSMB), Gilead, GSK/ViiV, Pfizer, and MSD; FN has funding for the submitted work by a Swedish government research grant through the ALF-agreement and from Formas, Swedish Research Council for Sustainable Development; FN has funding through research grants from the Swedish Research Council, Swedish Heart-lung foundation, SciLifeLab / Knut & Alice Wallenberg Foundation, and Swedish Social Insurance Agency; FN had a previous employment at Astra Zeneca until 2019 and owns some Astra Zeneca shares; no other relationships or activities that could appear to have influenced the submitted work."

"Funding MB is supported by a research grant from Svenska Sällskapet för Medicinsk Forskning SSMF (PD20-0012) and from the Swedish Research Council for Health, Working Life, and Welfare, (FORTE) (2022-00444). The underlying SCIFI-PEARL study has funding by a Swedish government grant through the ALF-agreement (ALFGBG-938453, ALFGBG-971130) and from Formas, a Swedish Research Council for Sustainable Development (2020-02828). MG received research grants from the ALF-agreement (ALFGBG-965885) and Formas (2021-06545). The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication."